Independent Model Shows Up to $11,142 Savings Per Member for Omada's GLP-1 Program
OMDA has more than doubled off its 52-week low of $10.28.
Summary
Omada Health released an independent cost savings model from GlobalData projecting up to $11,142 in gross medical cost savings per member over five years for its GLP-1 program. The model, based on data from nearly 25,000 Omada GLP-1 Care Track members, shows that medication persistence and engagement drive savings: members persisting 12+ months save about 30% more than those persisting 6 months ($11,142 vs $8,578), and highly engaged members save an additional $1,891. It also projects a 49% reduction in new-onset type 2 diabetes and 28% reduction in hypertension at five years. This follows Omada's Q2 2026 report of 43% revenue growth and 1.09M members, and provides concrete economic evidence to support employer adoption of its GLP-1 program. The findings could strengthen Omada's competitive position in the virtual cardiometabolic care market, where demonstrating long-term cost savings is critical for winning employer and health plan contracts.
At the time of this announcement, OMDA was trading at $22.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $10.28 to $26.92. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.